-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead Sciences Lowers FY2026 GAAP EPS Guidance from $(3.75)-$(3.40) to $(4.40)-$(4.05) vs $(3.44) Est

Benzinga·10/29/2026 20:11:00
Gilead Sciences (NASDAQ:GILD) lowers FY2026 GAAP EPS guidance from $(3.75)-$(3.40) to $(4.40)-$(4.05) vs $(3.44) analyst estimate..